摘要
Antibacterial agent combines C14 membrane disruption, SIPA hydrophilicity, charge moderation, and carboxyl grafting. • Initial release-killing combats infection during catheter insertion; robust contact-killing for sustained protection. • Outstanding long-term efficacy: > 85% against E.coli and > 95% against S.aureus after 14 days in PBS. • Charge-moderated antibacterial agent with CS hydration layer resists fouling, thrombosis, and sputum encrustation. The widespread use of implantable medical catheters is frequently associated with infections and biofouling issues, such as thrombus formation or mucus accumulation. Combining high antibacterial efficacy with antibiofouling properties has remained challenging, as the latter are often compromised by cationic or hydrophobic bactericidal agents. To overcome this conflict, we herein develop a charge-moderated antibacterial coating based on an amphiphilic ion-pair nano agent, 1-tetradecyl-3-methylimidazolium 5-sulfoisophthalate ([C14][SIPA]), and co -immobilize it with chondroitin sulfate (CS) through a polydopamine/poly(allylamine) (PDA/PAa)-mediated interfacial anchoring strategy. The resulting coating exhibits superhydrophilicity (water contact angle < 5°), and a negatively charged surface, which together reduce bacteria, proteins, platelets, and other biofouling via electrostatic repulsion and the dense physical hydration layer. Meanwhile, the coated catheter shows exceptional antibacterial activity through a two-stage defense mechanism: early-stage release-mediated killing of surrounding bacteria, followed by long-term surface-associated membrane disruption by retained [C14][SIPA] nanoaggregates. This coating strategy was applicable to representative catheter materials, including silicone rubber, polyurethane, and polyvinyl chloride, suggesting a versatile approach for balancing antibacterial activity, antibiofouling performance, and hemocompatibility on catheter surfaces. We introduce a multifunctional coating for implantable medical catheters to combat infections and biofouling. Utilizing a polydopamine-based layer-by-layer assembly, the coating integrates the amphiphilic ion-pair antibacterial agent 1-tetradecyl-3-methylimidazolium 5-sulfoisophthalate ([C14][SIPA]) with chondroitin sulfate (CS). Their coordinated interfacial organization enables high antibacterial efficacy and superhydrophilicity, providing broad-spectrum antifouling against thrombus and mucus accumulation. Download: Download high-res image (163KB) Download: Download full-size image
危险品化学品经营许可证(带存储)